Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea
Launched by PAMUKKALE UNIVERSITY · Oct 4, 2018
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
Our research will be carried out in Pamukkale University Faculty of Medicine Department of Emergency Medicine in 12 months period. There will be a research assistant and / or a faculty member who will control the research for 24 hours in our emergency department with approximately 110000 adult patients / year.
Study criteria: Female patients with primary dysmenorrhea (abdomino-pelvic pain) in the 18-45 age range. The onset of symptoms should usually be a few hours - 1 day before the onset of visible vaginal bleeding. Possible systemic symptoms such as nausea, vomiting, diarrhea, headache, ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients with primary dysmenorrhea (abdomino-pelvic pain) between the ages of 18-45.
- • The onset of symptoms should usually be a few hours - 1 day before the onset of visible vaginal bleeding.
- • Possible systemic symptoms such as nausea, vomiting, diarrhea, headache, fatigue, irritability, and dizziness are also questioned and recorded in the data form.
- • Patients with visual analogue scale score\> 5 and those who need or need nonsteroidal anti-inflammatory treatment.
- Exclusion Criteria:
- • Severe liver, kidney and heart failure; asthma, nasal polyp, angioedema and urticaria against aspirin or other nonsteroidal antiinflammatory drugs;
- • Active peptic ulcer, bleeding or perforation; to have a history of upper gastrointestinal disease;
- • Patients with phenylketonuria;
- • During pregnancy and lactation;
- • Have asthma;
- • Have taken analgesics in the last 4 hours;
- • The age of pregnancy and not using birth control method; digoxin, lithium, furosemide and other diuretics, acetylsalicylic acid and coumarin group using anticoagulants and physical examination of the suspicion of acute abdomen and signs of peritoneal irritation.
About Pamukkale University
Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Deni̇zli̇, , Turkey
Patients applied
Trial Officials
SEÇKİN ÇİFTÇİOĞLU
Principal Investigator
PAMUKKALE UNİVERSİTY HOSPİTAL EMERGENCY MEDİCİNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials